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ated for predicting carditic events in Pts with recent chest pain (CP)(onsets
12 hours) (n= 33) or ongoingcp (n = 19) and nondiagnostic (Non Dx) ECG
in the Emergency Depaflment. Pts with acute/old Ml were excluded. Rest
Tc.SPECT (15-25 mCi) imaging was performed in 52 Pts, 50?4.males, mean
age 58 yrs (+ 14.9), who were hospitalized to “rule out Ml”. Of these 52 Pts,
rest 2D echo was performed in 39 Pts, 46% males, mean age 57 yrs (+
15,3). Primary end points were in hospital cardiac death, Ml, and emergency
PTCA/CABG. 2D echo, Tc.SPECTand end points were reviewed blinded. 43
Pta (83%) were event free. No Pt died; 9 Pts (17%) had events. 01 Pts with
NL2D echo, 2r28 (4%) had events. Of Pts with NLTc.SPECT, 3/24 (6Yo)had
events. Sensitivity for all events was 87% (2D echo and Tc.SPECT); speci-
ficity 82% (2D echo) and 50% (Tc.SPECT); negative predictive value 93%
(2D echo) and 88’%(Tc.SPECT), (p = ns). When 2D echo was performed or
Tetrofosmin was injected during CP,negative predictive value was 100%.
Corrc/usion:In Pts with recent or ongoing cpand a Non Dx ECG,acute2D
echo, when feasible, and Tc.SPECT are comparable techniques. 2D echo
and Tc.SPECT, when normal, may be powerful predictors of cardiac event
free hospitalization when performed during cp.
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Many findings on transesophageal echocardiography (TEE) have been im-
plicated as causative of etroka without evidence for such causation. We
hypothesized that clinical risk factors, including previous stroke are the best
predictors of future stroke or death. Accordingly, 201 patients with stroke
prospectively underwent TEE, and were then followed for a mean of 2.5 +
1.2 yrs. Twelve patients died during initial hospitalization and 6 were lost to
follow-up. Of the remaining 183 patients, 35 had repeat strokes and 25 died
(total of 60 events, 33% over 2.5 yrs). On Cox regression analysis, none
of the findings on TEE predicted either repeat stroke or death. Clinical and
historical variables were the most important predictor of these eventa. For
repeat stroke, the positive predictors and their odds ratios were advanced
age (2.7), male gender (4.3), history of previous hypertension (5.9), and his-
tory of previous transient ischemic attack (3.8). For the occurrence of both
repeat stroke and death, the positive predictors and their odds ratios were
advanced age (2.7), male gender (2.4), and history of previous hypertension
(2.1), stroke (2.9), and diabetes (2.1). The prediotora that protected against
the occurrence of repeat stroke and their odds ratios were aspirin (-3.6) and
coumadin (-2.1) therapy. We conclude that strokes occur in patients with
traditional clinical rfskfactora, including histoy of previous transient ischemic
attacks. Subsequent mortality in thesepatientsis alsoaswciatedpositively
withtheseriakfactorsandnegativelywithaspirinandcoumadintherapy.In






M.Zabelgoitia,forthe SPAFInvestigators.University of TexasHea/th
sCienCeCenter at San Antonio, San Antonio, TX, USA





aize and function,spontaneousecho-contrast(SEC),and thrombuswere
prospectivelyasseased.
High-Risk(n= 387) Low-Risk(n= 336) p
Mean age (yrs) 71 67 0.001
Female (OA) 30 17 0.001




LAAthrombus(O/.) 10 4 0.001
LAAsize (cmz) 6,S + 2.9 6.4 & 2.7 0.07
LAAflowvelocities(crnlsac)
peak antegrade 33 i 22 38+ 25 o.ooa
peak retrogracls 35* 21 39* 24 0.006
mean antegrade 23* 19 26& 20 0.04
mean retrograde 22& 16 26& 16 0.01
In conclusion, TEE characteristics distinguish AFptsat high-riakforthrom-
boembolism. Higher LAA flow velocities in low-risk pts are aeeociated with
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While left atrial appendage (LAA) is known to harbor clots in patiente (pta)
with atrial fibrillation (AF), it is not known whether LAA morphology influenzas
thrombue formation. Previous studies have shown that IAA is often multi-
Iobedand that multiplanartransesophageal achocardiography (MPTEE)aide
in visualizing additional lobes. Toassess whether the presence ofadditiona/
LAA /obes was associated with increased riak of thrombosis, we performed
MPTEE proepactively in 160 pts with non-valvular AF (age 41-80 yra, 93
malee). Based on MPTEE, pts were ditiided into multilobed LAA ((88/160,
42.5%, group ML) and single-lobed LAA (92/180, 57.5%, group SL) groupe.
In these groups we evaluated the following parameters: presence of throm-
bus in LAA or in IA, LA size, LAA size at base, LAA peak flow velocity, AF
duration and LVejection fraction (EF). Results (groups ML vs. SL, chisquare
test and Student t test).’Presence of thrombus 14/66, 20% vs. 8/92, 9% (p =
0.03); LAsize 48.4+ 5.2 vs. 49.1 & 6.9 mm (p = NS); LAA peak flow velocity
22.2 + 11.9 vs. 23.1 + 12.7 crnhec (p = NS); AFduration 5 + 3.evs. 4.8 + 4.1
months (p = NS); EF 44,3 + 8.6 vs. 43.1 & 7.9% (p = NS). This obaetvation
that muftilobed LAA is associated with increaeed incidence of LAA thrombus
suggeets that the presenceof a morecomplex morphological architecture of
LAA may facilitate thrombus formation and represent an additional riakfactor
for embolism.
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(TEE)is an expensive,physicianintensive,invaeiveexam.To determine
howfrequentlyTEEprovidesnewinformation,the V.O.T.E.II etudyasked
referringMD’stheir pre-teetclinicaldiagnosis(dx) and probability(prob)
(high,medium,low)of thatdx beforeresultsof theTEEwereprovided.The
V.O.T.E.II study,an internationalconsortiumof tertiay referralinetitutione,
Pre TEE Pmb # New Conf New/Conf
High 41 .6% 56.7”A 28.3”/n 14.70/6
Med 32.3 70.4 23.9 5.6
Low 26,0 61.1 34.1 4,8
711 pt 62% 28.4% 9.3”/0
EMB 26.5”A 67.5 29,3 3.2
Endo 19.2 55.1 27,2 17.6
Valve 10.7 51.3 32.8 15.8
CHD 6.8 66,7 31.3 2.0
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gradedtheTEEaaconfirming(Conf)theMD’adx,providingnewinformation,
or both (New/Conf).Therewere 711 patientsatudiedwith a complication
rate of 1.3%.The most commonreferraldiagnoaeswere cardio-emtmlic
source(EMB)(26.5Yo),endocarditis(Endo)(19.2%),nativevalvedysfunction
(10.7%),andcongenitalheartdieeaae(CHD)(6.6%).
TEE revealednew informationin over60% of pts,and wasespecially
valuablein EMBpts. Thus,TEE providessignificantnew informationnot
expectedclinicallypre-teat.
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Trensesophagealecho(TEE)isa uaefuldiagnostictool in ptswithpotential
embollcstroke(CVA).Lessis knownabouttheyieldof TEEforotherpoten-
tial emboliceventssuchas transientischemicattack(TIA)and peripheral
emboiua(PE).Amaurosisfugex (AFG)has not beenreported.Thus,610
randomlyselectedpfs (649M/61F)meanage63 + 11yrawithrecentCVA
(n=376),TIA(n= 162),PE(n= 45)andAFG(n=25) werestudiedbyTEE.
101age-matchedptswithoutemboliwerecontrols(Cent).





LA/LV-thr Vsg Ao-plaque PFO ASA >1ES
Cent 1 (l%) 1(l%) 19 (19%) 14 (14%) 4 (49A) 39 (39”A)
CVA 24 (6°A)a 20(5%) 77(21%) 76(20%) 28(7”A) 21s(5S’L+
11A 12 (7X+ 7(4%) 49(30%)fJ 36(22%) 19(12%)a 113 (w%)d
PE 7(16%)0 1(2%) 12(27%) 7(16”/0) 1(2”/?) 31(69%)’
AFG 1 (4%) o(o%) 4(16%) 6(24”A) 4(16%)a 12(48%)
6P<0.05,bpz 0.02,Cpc O.OCM,‘p <0.0001vscent
Meanejectionfractionandfrequencyof regionalLVwall motionabnor-
malitywaaaimilaramonggroups.Conclusions:UnlikeCVA,TIA and PE,













referredfor both TEE and TTE to rule out a cardiacsourceof embolus
wereevaluated.In 10 pts, a cardiacsourceof emboluswas identifiedby
TEEcomparedto nonebyITE. MedicarereimbursementforTTE,TEEand
hospitalcostswereusedfor costanalysis.Usingthe bestestimatefor test
characteristicsandcosts,themostcost-effectiveatrategywasdependenton
the probabMtyof diseaae(POD)basedon predeterminedclinicalparame-
ters,includingatrialfibrillation,CAD,peripheralvasculardisease,prosthetic
valves,and congenitalanomalies.TEEshouldbe the first imagingmodal-
ity for ?64.1% PODand ITE for s54% POD,but mayeventuallyrequire
a subsequentTEE.Whendividedby specialty,ptsadmittedundercardiol-
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dogawereatriallypacedat 400bpm(3:1ventricularresponse)for 6 weeke,
andinstrumentedwithIeftatrial(IA) andleftventricular(LV)sonomicrometem
and micrornanometere.LA volume(IA Vol),ejectionfraction(EF), mean
normalizedsystolicejectionrate(SER),andreservoirfraction(RES,defined
as the fractionalchangein LA volumeduring ventricularsystole),ware
comparedwithdatafrom6 sham-operatedcontrols(SHAM)at matchedLA
pressureof 10mmHg.
LA Vol EF(%) SER(clrds) RES
AMYO (n. 8) 10.3+ 4.0 2.0 * *.4* 0.3 * 0.1’ 0.07*0.04*
SHAM (n=S) 7.9 *4.4 13.0 *4.O 2.8 + 1.2 0.35+0.06




thanSHAM(5.7+ 2.3vs.3.4+ 0.6mmHg),andtheratioof transeeophageal
echo-determinedpulmona~venoussystolicto diastolicintegratedfiow, a
measureof relativeresetvoirtoconduitfunctionofthe LA,wasleasinAMYO
comparedto SHAM(0.41+ 0.19va.0.66=k0.23cm,p < 0.05).Thus,in this










Mechanicalandrelaxationrestitution(MRand RR)are thoughtto be phys-
iologiccorrelatesof Ca2+handlingby the sarmplasmicreticulum(SR).
Althoughwe haverecentlyehownthat the proinflammatorycytokinetumor
necrosiafactor-a(TNFw)prolongsMRin a time-dependentmanner,the ef-
fectof TNFaon RRis not known.Accordingly,we studied5 autonomically
blocked(propranolol2 m@kg,atropine2 mg)coneciouadogainstrumented
withLVmanometersand3 diametergaugesbeforeandafterTNFuinfusion
(40@kg over1 hour).Afterprimingat a basiccyclelengthof 375ms,test
pulsesweredeliveredatgradedextrssyatolicintervals(ESIS).Therelaxation
reaponsesof extrasystoleswereaeeesaeduaingpeaknegativedP/dt,nor-
malizedto the precedingcontrolbeat,and relatedto the ESI.Valueaof the
earlyRRtimeconstants(TC)and steadystate measuresof tau, the time
constantof iaovoiumicrelaxation,areshown(* P c 0.06versusPre-TNFa):
Pre-TNFa 1 Hr Post 4 Hr Post 7 Hr Post 24 Hr Peat
TC (ins) 37.6zt S.l 40.6+ 1.7 56,7+ c3,8* 50.7+ 10.6 45.5 + 11.8
Tau (ins) 26.3i 1.6 24.7+ 0,9” 30.3 +2.5 32.0 i 2.7* 31.2 & 2.6*
Wecone/ude:TNFaimpairsRR4 hoursaftertreatment,withsubsequent
remvety at 7-24 hoursdespiteprolongationof tau. These date indicate
thatTNFaaltersrelaxationbehaviorin the intactheart.Divergenteffectsof
TNFaon RRandteusuggestthatthesetwoparametersrepreaentdifferent
undertyingmechanisms.
